This site uses features not supported by Internet Explorer.

Belviq

Eisai, Inc. voluntarily withdrew the weight loss medication Belviq and Belviq XR (lorcaserin) from the U.S. market following a U.S. Food and Drug Administration request. Data showed that patients who had taken the drug as part of a large clinical safety trial showed an increased occurrence of cancer five years later. 7.7% of the lorcaserin subjects developed cancer, compared to the placebo group. Cancers observed included pancreatic, colorectal, and lung.

Landing Pages

Belviq 2800 draft v2 bt7xs6

CAMG has thousands of spots and infomercials that can be branded for your firm. Reach out to us for the latest creative offline and online examples*.
*Examples shown are not always current examples.

Request Samples

* These fields are required.

Form image s e o card qhbib9

Our comprehensive SEO program is designed to get you in the Top 3 Google Search results and keep you there. Contact us today for a complimentary audit and review.

CONTACT

Image from i o s t6kzvw

CAMG Ethics White Paper

Now more than ever, ethics count.
“A Lawyer’s Ethics Obligations When Participating in a Lead Generation Program,” authored by a team of ethics and compliance attorneys, is continuously updated with the latest rules.

Learn More